Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (371-380 of 456) with videos related to

Pageof 46
Sort By:
Trends in Biochemical Sciences|July 2, 2026
Biochemistry at scale: Seeing both the forest and the treesStefan A Harry, Chirag Vasavda, Adam Wahida, et al.
Annals of Internal Medicine|October 1, 1976
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphomaP S Schein, V T DeVita, S Hubbard, et al.
Seminars in Oncology|April 1, 1988
Treatment of Pneumocystis carinii pneumonia with trimetrexate in acquired immunodeficiency syndrome (AIDS)C J Allegra, B A Chabner, C U Tuazon, et al.
The Journal of Infectious Diseases|August 1, 1989
Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agentsJ A Kovacs, C J Allegra, J Beaver, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolateJ A Kovacs, C J Allegra, J C Swan, et al.
The Oncologist|June 26, 2001
Losing GodR T Penson, R Z Yusuf, B A Chabner, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Molecular targets in the National Cancer Institute drug screenS E Bates, A T Fojo, J N Weinstein, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
AntimetabolitesE Chu, P G Johnston, J L Grem, et al.
The Journal of Clinical Investigation|October 1, 1985
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexateG A Curt, J Jolivet, D N Carney, et al.
Annals of Internal Medicine|March 1, 1983
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapyR I Fisher, V T DeVita, S M Hubbard, et al.
Pageof 46

Showing results (371-380 of 456) with videos related to

Sort By:
Pageof 46
Trends in Biochemical Sciences|July 2, 2026
Biochemistry at scale: Seeing both the forest and the treesStefan A Harry, Chirag Vasavda, Adam Wahida, et al.
Annals of Internal Medicine|October 1, 1976
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphomaP S Schein, V T DeVita, S Hubbard, et al.
Seminars in Oncology|April 1, 1988
Treatment of Pneumocystis carinii pneumonia with trimetrexate in acquired immunodeficiency syndrome (AIDS)C J Allegra, B A Chabner, C U Tuazon, et al.
The Journal of Infectious Diseases|August 1, 1989
Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agentsJ A Kovacs, C J Allegra, J Beaver, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolateJ A Kovacs, C J Allegra, J C Swan, et al.
The Oncologist|June 26, 2001
Losing GodR T Penson, R Z Yusuf, B A Chabner, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Molecular targets in the National Cancer Institute drug screenS E Bates, A T Fojo, J N Weinstein, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
AntimetabolitesE Chu, P G Johnston, J L Grem, et al.
The Journal of Clinical Investigation|October 1, 1985
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexateG A Curt, J Jolivet, D N Carney, et al.
Annals of Internal Medicine|March 1, 1983
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapyR I Fisher, V T DeVita, S M Hubbard, et al.
Pageof 46